Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder: As of June 15, 2023, the closing price of the Company's stock was 0.37 yuan per share, and the stock has closed below 1 yuan for 20 consecutive trading days (from May 19, 2023, to June 15, 2023). This has triggered the delisting regulations under the Shenzhen Stock Exchange Listing Rules (2023 Revision). Accordingly, the Company's stock will be suspended from trading starting June 16, 2023 (Friday), and there is a risk of termination of the stock listing.
According to Article 9.1.15 of the Shenzhen Stock Exchange Listing Rules (2023 Revision), "If a listed company's stock is forcibly delisted by the Exchange, it will enter a delisting transition period, except for cases of trading-related forced delisting." Therefore, the Company's stock will not enter a delisting transition period.
The stock of Jilin Zixin Pharmaceutical Co., Ltd. has closed below its par value (1 yuan) for 20 consecutive trading days (from May 19, 2023, to June 15, 2023). In accordance with relevant provisions of the Shenzhen Stock Exchange Listing Rules (2023 Revision), the Company hereby provides the following risk warning:
- According to Article 9.2.3 of the Shenzhen Stock Exchange Listing Rules (2023 Revision), if a listed company has a daily closing price below 1 yuan for ten consecutive trading days, it must disclose a risk warning announcement regarding the potential termination of its stock listing before the next trading day opens, and continue to disclose this information daily until the situation is resolved or the Shenzhen Stock Exchange makes a decision to terminate the stock listing (whichever comes first).